Medical News

RSS

AFFiRiS AG - Alzheimer's vaccines generate further cash flow

AFFiRiS AG announced today significant progress in their collaboration with GlaxoSmithKline Biologicals (GSK) for the development of an active vaccination programme against Alzheimer´s disease. While the lead vaccine candidate AD02 is currently in phase II clinical testing, two additional preclinical programmes have been completed successfully. The second programme was related to alternative vaccine candidates generated by AFFiRiS´ AFFITOME® technology, including candidate AD03. Based on the promising preliminary results of this programme, GSK exercised its option for the alternative vaccine candidates which triggered a EUR 2.5 million payment to AFFiRiS. An additional EUR 1 million payment became due simultaneously for the successful completion of tests of alternative vaccine formulations.

28 Feb 2011

UCSF collaborates with Zcube to develop new ways to deliver drugs

A pill filled with microscopic, drug-laden adhesive squares is at the center of an agreement between UCSF and Zcube srl, the research corporate venture arm of Italian pharmaceutical leader Zambon Co., SpA, to license UCSF-developed microtechnology and support early research into new ways to deliver oral medications directly to a targeted site in the body.

28 Feb 2011

EDMA supports the Rare Disease Day

On the occasion of the 2011 Rare Disease Day, EDMA, the European Diagnostic Manufacturers Association, underlines the crucial role the In Vitro Diagnostic industry can play to diagnose rare diseases.

28 Feb 2011

TCD announces first patient treated in its TCD-717 Phase I trial

Traslational Cancer Drugs Pharma, S.L. (“TCD”) announced today that the first patient was treated on Friday the 18th of February with TCD-717 in a Phase I study performed in patients with advanced solid tumors. TCD-717 is a first-in-class, small molecule that precisely inhibits Choline Kinase Alpha, an enzyme heavily involved in the carcinogenic process. A total of 30 patients are planned to be treated in the trial, which will be conducted in accordance with FDA approval, in two leading medical centers in the U.S. The Principal Investigators are Dr. Julie Brahmer at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital in Baltimore; and Dr. Patricia LoRusso at the Barbara Ann Karmanos Cancer Institute in Detroit.

28 Feb 2011

Katie Couric to launch new citywide campaign for colon cancer screenings

In honor of National Colon Cancer Awareness Month, Katie Couric, the New York City Department of Health and Mental Hygiene, WCBS-TV and The Jay Monahan Center for Gastrointestinal Health at NewYork-Presbyterian Hospital will launch the "Make That Call" for colon cancer screening campaign.

28 Feb 2011

Apparently mindless survival strategies best for long-term success of genes

Blindly copying what your parents did - no matter how stupid it may seem - could be the best strategy for the long-term success of your genes, according to research by the Universities of Exeter and Bristol.

28 Feb 2011

ACT Biotech files SPA with FDA for telatinib combination Phase 3 trial for stomach cancer

ACT Biotech, Inc., a biopharmaceutical company focused on the development of highly targeted, oral therapeutics for the treatment of cancer, announced today that it has filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) related to a randomized Phase 3 trial of telatinib in combination with chemotherapy for the first-line treatment of patients with advanced stomach cancer.

28 Feb 2011

Obama administration awaiting next reform ruling from Florida judge

Politico reports that the expected ruling could be another blow for the White House. Meanwhile, The Hill analyzes the importance of the fact that all the judges who have ruled thus far on health law challenges have agreed that the individual mandate involves a penalty, not a tax.

28 Feb 2011

LWW launches Orthopaedics Network

Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health, today announced the launch of Orthopaedics Network (www.orthopaedicsnetwork.com), a single source solution that provides orthopaedists quick access to all the current articles from the collection of LWW-published orthopaedics journals.

28 Feb 2011

Health law ups the ante in state-federal Medicaid budget battle

As this health insurance program for low-income people continues to place a huge burden on state budgets, governors are pressing for more flexibility regarding Medicaid's eligibility standards. The health law's expansion of this program — scheduled to take effect in 2014 — adds a sense of imperative to the conversation, as do the spending cuts being considered by Congress.

28 Feb 2011

Dialogue with children about healthy habits very important

Health is a hot topic amongst adults. But, dialoguing with children about healthy habits is equally important. Kids, today, need to be as proactive as adults in managing their health by making wholesome choices--whether for food or for their daily activities.

28 Feb 2011

UCH installs GE's CARESCAPE Monitor B850 to enhance clinical decision making in the NICU

GE Healthcare today announced that the University of Colorado Hospital (UCH) has installed the new CARESCAPE™ Monitor B850, the company's latest advance in bedside patient monitoring, to help enhance clinical decision making in the Neonatal Intensive Care Unit (NICU). Deployed in UCH's 50-bed NICU and Neonatal OR, the CARESCAPE Monitor B850 enables access to critical patient information from any bedside monitor anywhere in the unit.

28 Feb 2011

Regulators face challenge of defining 'essential care' benefits

As federal regulators — in their efforts to implement the health law — work to define what basic medical services health insurers must cover under the measure, another set of regs, those dealing with accountable care organizations, are stalled at the Office of Management and Budget.

28 Feb 2011

UM CAS awarded Howard Hughes Medical Institute grant

The University of Miami's College of Arts and Sciences and Miller School of Medicine were recently awarded a Howard Hughes Medical Institute grant to design and assess an innovative competency-based premedical curriculum in response to the 2009 American Association of Medical Colleges-Howard Hughes Medical Institute "Scientific Foundations for Future Physicians (SFFP)" report. The grant will be in collaboration with Purdue University, University of Maryland, Baltimore County, and University of Maryland at College Park.

28 Feb 2011

Politics play into state-level implementation issues

The AP reports on how some GOP governors are flexing their political muscle to undermine the health law. Meanwhile, a Democratic governor is considering using her veto power on a bill passed by the state legislature that challenges the federal law.

28 Feb 2011

Cryo-Cell fiscal 2010 net income increases to $3.4 million

Cryo-Cell International, Inc., one of the world's largest and most established family cord blood banks and an industry leader of innovative stem cell solutions, today announced results for its fiscal year 2010.

28 Feb 2011

Capario releases Portal v3.7 of provider portal application

Capario, a leading provider of revenue cycle management solutions that connect healthcare payers and providers nationwide, announces the release of version 3.7 of its provider portal application, which features new services and system enhancements based on submitter feedback. The release also contains Capario's 5010 submitter testing tool.

28 Feb 2011

BrainStorm raises $3.6 million through private placement financing

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, announced today that it has entered into securities purchase agreements with certain institutional and other investors in connection with a private placement financing in reliance upon Regulation S. BrainStorm received gross proceeds of approximately $3.6 million resulting from the sale of shares at a purchase price of $0.28 per share at the closing of the transaction.

28 Feb 2011

Free radicals make the heart to beat with the correct force

Fear of free radicals may be exaggerated, according to scientists from the Swedish medical university Karolinska Institutet. A new study, published in the Journal of Physiology, shows that free radicals act as signal substances that cause the heart to beat with the correct force.

28 Feb 2011

'Romneycare' continues to draw political focus

As one former GOP governor softens his criticism, Massachusetts' current Democratic governor chimes in with kudos for the state health overhaul that Romney oversaw when he was that state's chief executive.

28 Feb 2011